JPRN-UMIN000011241
Completed
未知
The effects of budesonide/formoterol maintenance and reliever therapy on airway inflammation in asthma patients; open label, randomized parallel group comparison study with fluticasone/salmeterol - The effects of SMART on airway inflammation in asthma patients
Hiroshima Allergy and Respiratory Clinic0 sites30 target enrollmentJuly 21, 2013
ConditionsBronchial asthma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Bronchial asthma
- Sponsor
- Hiroshima Allergy and Respiratory Clinic
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •\-Patients with a history of hypersensitivity (including contact dermatitis) to any ingredient contained in the study drugs \-Patients with infections with no available effective antimicrobial drugs or with deep seated mycosis \-Patients with tuberculosis \-Patients with rhinitis needed to be treated clinically \-Respiratory infection, judged by the investigator as an infection affecting the asthma, within 8 weeks prior to enrollment \-Use of any beta\-blocking agents (including eye\-drops) \-Treatment with oral, parenteral or rectal steroids within 30 days prior to enrollment \-Any significant disease or disorder judged by the investigator \-Current or previous with a smoking history,10 pack years or more, or smoking cessation no longer than 6 months prior to enrollment \-Pregnancy, breast\-feeding or planned pregnancy during the study \-Suspected poor capability, as judged by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effects of budesonide and formoterol combination on airway regulatory T cells in mild asthmaticsJPRN-UMIN000004275Division of respirology, neurology, and rheumatology, Department of medicine, Kurume University School of Medicine10
Completed
Not Applicable
Improved effects of Budesonide/Formoterol combination therapy (Symbicort) on the residual eosinophilic inflammation in the distal airways of asthmatic patients who used the salmeterol/fluticasone combination drugBronchial asthmaJPRN-UMIN000003805JA Tohno Kousei Hospital40
Completed
Not Applicable
Study on the effects of the budesonide/formoterol combination formulation in improving airway inflammation and airway resistance in patients with bronchial asthmaPatients with bronchial asthma aged 20 years and older (males and females, outpatients and inpatients) being treated with an ICS (at a dose equivalent to FP 200-1000 mcg/day) and salmeterol 100 mcg/day in combination (either as two separate products or one combined product) for 3 months or longer with poor or inadequate controlJPRN-UMIN000006572Chiba-Hokusoh Hospital, Nippon Medical School80
Completed
Not Applicable
Clinical effects of budesonide/formoterol in patients with asthmaBronchial asthmaJPRN-UMIN000003745Atami Hospital International University of Health and Welfare30
Recruiting
Not Applicable
Budesonide/formoterol maintenance reliever therapy versus fluticasone furoate /vilanterol fixed-dose treatment of asthma on airway inflammation with adult asthma in 4-week treatment;Open-label, randomized, parallel-group comparative studyBronchial asthmaJPRN-UMIN000017042Hiroshima Allergy and Respiratory Clinic30